Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Retraction Note: Novel piperazine core compound induces death in human liver cancer cells: possible pharmacological properties

The Original Article was published on 13 April 2016

Scientific Reports 6: Article number: 24172; published online: 13 April 2016; updated: 22 June 2016

This Article has been retracted by the Editors and Publishers of Scientific Reports. Following online criticisms of the published paper, an investigation at the journal has confirmed the manipulation and duplication of data and a level of image processing that is not compliant with the journal’s policies on image data integrity in figures 1–3, 6, 7, 10 and 12. Versions of figures 1–11 and large sections of the text had also previously been published1,2.

All authors acknowledge these issues and agree to the retraction of the Article.

References

  1. 1

    Samie, N. et al. Mechanism of Action of the Novel Nickel(II) Complex in Simultaneous Reactivation of the Apoptotic Signaling Networks Against Human Colon Cancer Cells. Front. Pharmacol. 6, 313 (2016). 10.3389/fphar.2015.00313

    CAS  Article  Google Scholar 

  2. 2

    Samie, N., Muniandy, S., Kanthimathi, M. S. & Haerian, B. S. Mechanism of action of novel piperazine containing a toxicant against human liver cancer cells. PeerJ 4, e1588 (2016). 10.7717/peerj.1588

    CAS  Article  Google Scholar 

Download references

Authors

Additional information

The online version of the original article can be found at 10.1038/srep24172

Rights and permissions

This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Samie, N., Muniandy, S., Kanthimathi, M. et al. Retraction Note: Novel piperazine core compound induces death in human liver cancer cells: possible pharmacological properties. Sci Rep 6, 29056 (2016). https://doi.org/10.1038/srep29056

Download citation

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing